Back to BlackRock, Inc. BlackRock, Inc.

IMVTIMVT
7 quarters

Position history for BlackRock, Inc.BlackRock, Inc.'s holdings in IMMUNOVANT INC

BlackRock, Inc. holds 7.2M shares of IMVT (IMMUNOVANT INC), worth $276.7M as of 2026-Q2. The position was increased (+9.2% shares). IMVT represents 0.0% of BlackRock, Inc.'s portfolio.

Current Value

$276.7M

Current Shares

7.2M

Total Value Change

+$149.3M

Total Shares Change

+2M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
7.2M
+9.2%
$276.7M0.0%$38.53
34
2026-Q1
Increased
6.6M
+8.5%
$163.3M0.0%$26.71
33
2025-Q4
Increased
6.1M
+5.6%
$154M0.0%$25.35
32
2025-Q3
Decreased
5.7M
-1.9%
$92.5M0.0%$16.06
0
2025-Q2
Increased
5.8M
+9.0%
$93.6M0.0%$16.10
33
2025-Q1
Increased
5.4M
+4.3%
$91.7M0.0%$18.37
31
2024-Q4
New
5.1M
-
$127.4M0.0%$23.88
42

Other major holders of IMVT: FMR LLC, RTW INVESTMENTS, LP

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used